Get started

Cipla

Natco Pharma for 45%+ gainsDate: 21 Nov’24 Symbol: NATCOPHARM Timeframe: Daily Natco Pharma currently seems to be in Wave IV of 3 which could end around 1240-1220 and Wave V could then head towards 1800-1900 levels (45%+ from where Wave IV would end) as seen in the chart. A more precise target can be pinned once it makes a fresh ATH. Two levels (1770 & 1900) have been marked as possible supply zone. The company recently posted good Q2 numbers. The stock is currently trading at a PE multiple of 12.6 while the industry average is around 32. This is not a prediction but a possible wave count. This is also not a recommendation to trade or invest. Please do your own analysis. HINGLISH VERSION Natco Pharma vartamaan mein 3 ke Wave IV mein hai, jo 1240-1220 ke aaspaas samaapt ho sakta hai aur Wave V phir 1800-1900 ke star (45%+ jahaan Wave IV samaapt hoga) kee taraf badh sakta hai, jaisa ki chart mein dekh sakte hain. Ek baar naya ATH banaane par adhik sateek target pin kiya ja sakta hai. Do staron (1770 aur 1900) ko sambhaavit supply zone ke roop mein mark kiya gaya hai. Company ne haal hee mein achhe Q2 ke numbers post kiye hain. Stock vartamaan mein 12.6 ke PE multiple par kaarobaar kar raha hai jabki industry ka average lagbhag 32 hai. Yah koee bhavishyavaanee nahin balki sambhaavit Wave count hai. Yah trade lene ya invest karne ki bhi salaah nahi hai. Kripya apana vishleshan svayan karen.
NSE:NATCOPHARMLong
by DhandhaPaani
Granules India for 35%+ gainsDate: 3 Oct’24 Stock: Granules Timeframe: Daily chart Granules India seems to have begun its up move in Wave V of 5 which could end around 810-820 (>35% from current price of 595) as seen in the chart. High volumes and strong reversal of RSI supports this stance. This is not a trade recommendation. Please do your own analysis. Aisa lagata hai ki Granules India ne 5 ke Wave V mein apni badhat shuroo kar dee hai, jo 810-820 (595 kee vartamaan keemat se 35%) ke aasapaas samaapt ho sakatee hai, jaisa ki chart mein dekh sakte hain. Achhi volume aur RSI ka majaboot ulataav is rukh ka samarthan karta hai. Yeh koi vyaapaar ki rai nahin hai. Kripya apna vishleshan khud karein.
NSE:GRANULESLong
by DhandhaPaani
2
CIPLA -Rising wedge BreakoutCIPLA-Rising -Rising wedge Breakout Name - CIPLA Pattern - Rising wedge Status - BreakOut with good volume Cmp - 1654 Target - 1850 SL - 1600 Pattern A rising wedge pattern is a technical analysis tool that often signals a potential bearish reversal. It forms when the price of an asset is moving upward, but the trendlines converge, indicating a loss of momentum. When the price breaks below the lower trendline, it typically suggests a downward move. Fundamentals : Here are some key financial ratios for Cipla Limited: Price-to-Earnings (PE) Ratio: 28.71 Debt-to-Equity Ratio: 0.021 Return on Equity (ROE): 16.8%1 Net Profit Margin: 16.5%2 Revenue Growth (TTM): 10.3%2 Enterprise Value to EBITDA: 19.813 Price-to-Sales Ratio: 4.943 These ratios indicate Cipla’s strong financial health, low leverage, and efficient profitability. The company is well-positioned in the pharmaceutical industry with a solid market presence.
NSE:CIPLALong
by VCharts_TA
3
CIPLA BULLISH VIEWCIPLA Now is the right time to invest in cipla Cipla is ready to break out the resistance trend line Volumes are also good my first target@1540 Second target@1660 Stop loss@1317 Disclaimer: I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade. Happy trading. Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India. so please keep CIPLA in your watchlist for long term investment. If yoU like my view, do support it with a boost witch is valuable inspiration for me to post ideas like this in future. thank you friends!
NSE:CIPLALong
by Ashokdyavan123
CNXPHARMA - Trend Reversal📊 Script: CNXPHARMA (NIFTY PHARMA) Key highlights: 💡⚡ 📈 Nifty Pharma is retesting from its support level shown in chart. 📈 Pharma stocks can give good returns. 📈 One can go for Swing Trade into Pharma stocks. 📊 Script: CIPLA ⏱️ C.M.P 📑💰- 1414 🟢 Target 🎯🏆 - 1510 📊 Script: LUPIN ⏱️ C.M.P 📑💰- 1688 ONLY ABOVE 1700 🟢 Target 🎯🏆 - 1828 📊 Script: AUROPHARMA ⏱️ C.M.P 📑💰- 1177 🟢 Target 🎯🏆 - 1267 📊 Script: GLAND ⏱️ C.M.P 📑💰- 1177 🟢 Target 🎯🏆 - 1267 📊 Script: BIOCON ⏱️ C.M.P 📑💰- 1177 🟢 Target 🎯🏆 - 1267 ⚠️ Important: Always maintain your Risk & Reward Ratio. ✅Like and follow to never miss a new idea!✅ Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes. Eat🍜 Sleep😴 TradingView📈 Repeat 🔁 Happy learning with trading. Cheers!🥂
NSE:CNXPHARMALong
by radha_23
CIPLA - Ready, Steady, Go!!#CIPLA Stock gave decent correction last month. Reversed from 1335 levels, then formed a strong damand zone at the level - 1390-1400. Now earning is there. Market is signing up for the second phase. I never believe that news makes chart. For me chart and technicals are always formed first, many days before, and then news comes into the market. So as per the chart we can expect a good earning result from Cipla. The best entry point as per technicals, is at 1435. Stoploss can be seen around 1392-1390 levels on daily closing basis. The first target we can achieve is at 1500-1520 levels. And if we are able to close above this even on 4 hours candle then target of 1660-1665 can be achived very very soon. I give classes to #masterclass in live market with practical assignments so won't be able to give much updates. But you don't need it anyway because these are technicals levels and are well defined as per market direction. This is not a buy/sell reccomendation but a pure study of how we can pick a stock for #SwingTrading. So rather than to jump directly on earning, better focus few days on learning. Because, Believe or not - Learning is Earning. Cheers!
NSE:CIPLALong
by Trendxinc
Positional_ CiplaCipla looks good for a positional trade. Buy above Rs 961.80, SL 942. Target will be set afterwards, we may also trail our SL/Target considering the market behavior. The entry price may also be modified depending on various circumstances. Disclaimer: The views expressed in this article is of my own. You're solely responsible for any decision taken in the markets, resulting in financial gains or losses. The analysis I've shared is for informational and educational purposes only.
NSE:CIPLALong
by UnknownUnicorn7637383